(Q34407769)

2 August 2017

title

Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator Group (English)

1 reference

2 August 2017

1 reference

Bate CM

1

1 reference

2 August 2017

Booth SN

2

1 reference

2 August 2017

Crowe JP

3

1 reference

2 August 2017

Mountford RA

4

1 reference

2 August 2017

Keeling PW

5

1 reference

2 August 2017

Hepworth-Jones B

6

1 reference

2 August 2017

Taylor MD

7

1 reference

2 August 2017

Richardson PD

8

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 1995

1 reference

2 August 2017

1 reference

2 August 2017

volume

36

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

492-498

1 reference

Does 40 mg omeprazole daily offer additional benefit over 20 mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux oesophagitis?

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1382485

A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Restore Investigator Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1382485

Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1382485

Low dose omeprazole effects on gastric acid secretion in normal man.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1382485

Prevention of Relapse of Reflux Esophagitis after Endoscopic Healing: The Efficacy and Safety of Omeprazole Compared with Ranitidine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1382485

Australian clinical trials of omeprazole in the management of reflux oesophagitis

6 July 2018

1 reference

12 December 2020

Variability in individual response to various doses of omeprazole

1 reference

12 December 2020

Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy

1 reference

12 December 2020

Clinical and economic factors in the selection of drugs for gastroesophageal reflux disease

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.36.4.492

1 reference

release_4w4kudlqave45npcfooahd3dgm

2 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4w4kudlqave45npcfooahd3dgm

24 November 2022

mapped directly with Wikidata item

PMC publication ID

1382485

1 reference

2 August 2017

1 reference